Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Carcinoma, Non-Small-Cell Lung 10Lung Neoplasms 5Recurrence 4Neoplasm Metastasis 4Ovarian Neoplasms 2Lymphoma, T-Cell, Peripheral 2Lymphoma, T-Cell 2Lymphoma, B-Cell 2Head and Neck Neoplasms 2Breast Neoplasms 2Waldenstrom Macroglobulinemia 1Urinary Bladder Neoplasms 1Thyroid Diseases 1Smoking 1Psoriasis 1Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Lymphoma, Non-Hodgkin 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Extranodal NK-T-Cell 1Lymphoma 1Leukemia 1Laryngeal Diseases 1Immunoblastic Lymphadenopathy 1Hyperbilirubinemia 1Hodgkin Disease 1Folic Acid Deficiency 1Fallopian Tube Neoplasms 1Carcinoma, Transitional Cell 1

Interventions

Cisplatin 4Cetuximab 4Pemetrexed 3N-benzhydryl-5-(2-(methylamino)propanamido)-3-(3-methylbutanoyl)-6-oxodecahydropyrrolo(1,2-a)(1,5)diazocine-8-carboxamide 2Gemcitabine 2pembrolizumab 1monalizumab 1durvalumab 1X-Rays 1Vitamin B 12 1Radiotherapy, Intensity-Modulated 1Radiotherapy 1Radiation 1Proflavine 1Paclitaxel 1Modafinil 1Minocycline 1Metformin 1Gefitinib 1Gabapentin 1Folic Acid 1Fibroblast Growth Factor 7 1Drug Therapy 1Docetaxel 1Chemical Fractionation 1Carboplatin 1Bupropion 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Laryngeal Diseases × Folic Acid × Clear all
NCT01057589 2013-09-18

A Study for Patients With Recurrent or Metastatic Squamous Cell Head and Neck Cancer

Eli Lilly and Company

Phase 2 Completed
66 enrolled 11 charts
Head & Neck

Head and Neck Neoplasms, Laryngeal Diseases, Thyroid Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡